Korro Bio, Inc. (NASDAQ:KRRO), a pharmaceutical company specializing in preparations with a market capitalization of $285 million, announced today that Vineet Agarwal, the company's Chief Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback